Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative

The purpose of this quality improvement initiative is to explore whether an electronic medical records-based templated progress note for polycythemia vera (PV) in addition to a standard-of-care pharmacist-collaborative ropeginterferon alfa-2b titration service is feasible, acceptable, and appropriate for clinicians who manage PV.

NCT Number	NCT07734272
Lead Sponsor	Massachusetts General Hospital Collaborators: PharmaEssentia
Conditions	Polycythemia Vera
Enrollment	32 participants
Start Date	2026-08-05
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-29